Clinical Trial Update: The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the Cordis SMART Stent System with the Bard Luminexx Stent has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Cordis SMART Stent System
• Luminexx Stent

Snippet

Sponsor: Cordis US Corp. | Conditions: Arterial Occlusive Diseases | Phase 4 | Status: COMPLETED